Provision of continuous subcutaneous insulin infusion to type 1 diabetes ‘frequent flyers’

Lisa A. Amato; Romana Kalolo; William Yu; David Simmons

doi:10.1111/imj.16213

Provision of continuous subcutaneous insulin infusion to type 1 diabetes ‘frequent flyers’

Lisa A. Amato
, Romana Kalolo
, William Yu
, David Simmons

Western Sydney University

SWSLHD

Research output: Contribution to journal › Article › peer-review

Abstract

A few people with type 1 diabetes undergo multiple hospital admissions for acute glycaemic events. We report on a series of five such ‘frequent flyers’ who were provided with continuous subcutaneous insulin infusion (CSII) therapy. Mean HbA1c decreased from 9.7 ± 2.5% (83 ± 27 mmol/mol) to 7.9 ± 0.4% (63 ± 4.7 mmol/mol) after 2–4 months. Frequency of admissions for acute glycaemic events reduced in three but increased in two patients within 6 months. Total insulin dose and body mass index decreased in some patients and satisfaction was anecdotally higher. Some, but not all, ‘frequent flyers’ benefited from a trial of CSII.

Original language	English
Pages (from-to)	1706-1711
Number of pages	6
Journal	Internal Medicine Journal
Volume	53
Issue number	9
DOIs	https://doi.org/10.1111/imj.16213
Publication status	Published - Sept 2023

Bibliographical note

Publisher Copyright:
© 2023 The Authors. Internal Medicine Journal published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Physicians.

Open Access - Access Right Statement

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

type 1
mental health
patient readmission
diabetes mellitus
glycaemic control
insulin infusion systems

Access to Document

10.1111/imj.16213

Cite this

@article{9dd874279dc44f018cc6ea7ef98d5bf8,

title = "Provision of continuous subcutaneous insulin infusion to type 1 diabetes {\textquoteleft}frequent flyers{\textquoteright}",

abstract = "A few people with type 1 diabetes undergo multiple hospital admissions for acute glycaemic events. We report on a series of five such {\textquoteleft}frequent flyers{\textquoteright} who were provided with continuous subcutaneous insulin infusion (CSII) therapy. Mean HbA1c decreased from 9.7 ± 2.5\% (83 ± 27 mmol/mol) to 7.9 ± 0.4\% (63 ± 4.7 mmol/mol) after 2–4 months. Frequency of admissions for acute glycaemic events reduced in three but increased in two patients within 6 months. Total insulin dose and body mass index decreased in some patients and satisfaction was anecdotally higher. Some, but not all, {\textquoteleft}frequent flyers{\textquoteright} benefited from a trial of CSII.",

keywords = "type 1, mental health, patient readmission, diabetes mellitus, glycaemic control, insulin infusion systems",

author = "Amato, \{Lisa A.\} and Romana Kalolo and William Yu and David Simmons",

note = "Publisher Copyright: {\textcopyright} 2023 The Authors. Internal Medicine Journal published by John Wiley \& Sons Australia, Ltd on behalf of Royal Australasian College of Physicians.",

year = "2023",

month = sep,

doi = "10.1111/imj.16213",

language = "English",

volume = "53",

pages = "1706--1711",

journal = "Internal Medicine Journal",

issn = "1444-0903",

publisher = "John Wiley and Sons Inc",

number = "9",

}

TY - JOUR

T1 - Provision of continuous subcutaneous insulin infusion to type 1 diabetes ‘frequent flyers’

AU - Amato, Lisa A.

AU - Kalolo, Romana

AU - Yu, William

AU - Simmons, David

PY - 2023/9

Y1 - 2023/9

N2 - A few people with type 1 diabetes undergo multiple hospital admissions for acute glycaemic events. We report on a series of five such ‘frequent flyers’ who were provided with continuous subcutaneous insulin infusion (CSII) therapy. Mean HbA1c decreased from 9.7 ± 2.5% (83 ± 27 mmol/mol) to 7.9 ± 0.4% (63 ± 4.7 mmol/mol) after 2–4 months. Frequency of admissions for acute glycaemic events reduced in three but increased in two patients within 6 months. Total insulin dose and body mass index decreased in some patients and satisfaction was anecdotally higher. Some, but not all, ‘frequent flyers’ benefited from a trial of CSII.

AB - A few people with type 1 diabetes undergo multiple hospital admissions for acute glycaemic events. We report on a series of five such ‘frequent flyers’ who were provided with continuous subcutaneous insulin infusion (CSII) therapy. Mean HbA1c decreased from 9.7 ± 2.5% (83 ± 27 mmol/mol) to 7.9 ± 0.4% (63 ± 4.7 mmol/mol) after 2–4 months. Frequency of admissions for acute glycaemic events reduced in three but increased in two patients within 6 months. Total insulin dose and body mass index decreased in some patients and satisfaction was anecdotally higher. Some, but not all, ‘frequent flyers’ benefited from a trial of CSII.

KW - type 1

KW - mental health

KW - patient readmission

KW - diabetes mellitus

KW - glycaemic control

KW - insulin infusion systems

UR - https://hdl.handle.net/1959.7/uws:73297

UR - https://www.scopus.com/pages/publications/85169825660

U2 - 10.1111/imj.16213

DO - 10.1111/imj.16213

M3 - Article

C2 - 37665715

SN - 1444-0903

VL - 53

SP - 1706

EP - 1711

JO - Internal Medicine Journal

JF - Internal Medicine Journal

IS - 9

ER -

Provision of continuous subcutaneous insulin infusion to type 1 diabetes ‘frequent flyers’

Abstract

Bibliographical note

Open Access - Access Right Statement

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this